The FDA hopes the dashboard will increase transparency by making it easier for people to access reports the FDA receives. Its revised system features a tool that helps users search and organize data by drug product, patient age, type of adverse event or timeframe the event occurred.
However, FAERS data, by themselves, are not a safety indicator of the drug or product, FDA Commissioner Scott Gottlieb, MD, warned Monday.
“Patients should still talk to their healthcare professional if they have any concerns regarding their medications,” he said in a statement.
More articles on supply chain:
US Army delivers 3-day fuel supply to Puerto Rican children’s hospital
Rite Aid names former Walgreens executive as president, COO
5 drug, devicemakers in the headlines
